Form 4: PepGen Director Laurie Keating Granted 16,000 Stock Options

PepGen Inc. Director Laurie Keating was granted 16,000 stock options with an exercise price of $1.51, aligning her interests with shareholder value.

Summary

• Laurie Keating, a Director of PepGen Inc. (PEPG), was granted 16,000 stock options.
• The transaction date for this grant was June 4, 2025.
• Each stock option has an exercise price of $1.51.
• The options will vest in full upon the earlier of the first anniversary of the grant date (June 4, 2026) or the date of the next Annual Meeting.
• Vesting is contingent on Ms. Keating continuing to serve as a director, unless the Board of Directors determines otherwise.
• The expiration date for these options is June 3, 2035.
• Following this transaction, Ms. Keating beneficially owns 16,000 derivative securities directly.

Sentiment

Score: 6

Explanation: The grant of stock options to a director is a positive event for corporate governance and alignment of interests, though it is a routine disclosure and not indicative of significant operational or financial news.

Positives

• The grant of stock options to Director Laurie Keating aligns her financial interests with the long-term performance and shareholder value of PepGen Inc.
• Equity compensation is a standard practice to incentivize directors and retain talent.

Future Outlook

The stock options granted to Director Laurie Keating are set to vest upon the earlier of June 4, 2026, or the date of the next Annual Meeting, provided she continues her service as a director.

Industry Context

The granting of stock options to directors is a common form of equity compensation across various industries, including biotechnology, to incentivize long-term commitment and align leadership interests with company performance.

Comparison to Industry Standards

• The grant of stock options to a director is a standard practice for public companies, comparable to compensation structures seen in biotech firms of similar size to PepGen Inc. (PEPG).
• The vesting schedule, tied to continued service or an annual meeting, is typical for director equity awards, aiming to retain experienced board members.

Corporate Governance

Related Party Transactions

• The grant of 16,000 stock options to Laurie Keating, a Director of PepGen Inc., constitutes a related party transaction as it involves compensation to a member of the company's board.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with shareholder value, potentially leading to more favorable long-term decisions.
• Employees: No direct impact on general employees is indicated by this specific filing.

Next Steps

• The stock options will vest upon the earlier of June 4, 2026, or the date of the next Annual Meeting, subject to continued service.

Key Dates

Keywords

PepGen Inc., PEPG, Stock Options, Equity Compensation, Director Grant, Insider Transaction, Form 4, Laurie Keating, Beneficial Ownership